Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
P612723-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $420.90 | |
P612723-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,120.90 |
Synonyms | PF-03654746|935840-31-6|PF 03654746|G3QE979K1X|CHEMBL2151197|(1R,3R)-N-Ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)cyclobutane-1-carboxamide|N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide|N-ethyl-3-fl |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Histamine H3 receptor antagonist |
Product Description | PF-03654746 is a potent and selective histamine H3 receptor antagonist with high brain penetration. PF-03654746 reduces allergen-induced nasal symptoms, might be a novel therapeutic strategy to further explore allergic rhinitis. PF-03654746 improves cognitive efficacy and disease-modifying effects in Alzheimer's disease (AD) |
ALogP | 2.5 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide |
---|---|
INCHI | InChI=1S/C18H24F2N2O/c1-2-21-17(23)14-10-18(20,11-14)15-6-5-13(16(19)9-15)12-22-7-3-4-8-22/h5-6,9,14H,2-4,7-8,10-12H2,1H3,(H,21,23) |
InChi Key | SXMBKHYDZOCBMT-UHFFFAOYSA-N |
Canonical SMILES | CCNC(=O)C1CC(C1)(C2=CC(=C(C=C2)CN3CCCC3)F)F |
Isomeric SMILES | CCNC(=O)C1CC(C1)(C2=CC(=C(C=C2)CN3CCCC3)F)F |
Alternate CAS | 935840-31-6 |
PubChem CID | 16119086 |
MeSH Entry Terms | N-ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidinylmethyl)phenyl)cyclobutanecarboxamide;PF 03654746;PF-03654746;PF03654746 |
Molecular Weight | 322.39 |
Wikipedia | PF-03654746 |
---|---|
CAS Registry No. | 935840-31-6 |
ChEMBL Ligand | CHEMBL2151197 |
BindingDB Ligand | 50401003 |
PubChem CID | 16119086 |
GPCRdb Ligand | PF-03654746 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2409106 | Certificate of Analysis | Jun 14, 2024 | P612723 |
G2409108 | Certificate of Analysis | Jun 14, 2024 | P612723 |
G2409110 | Certificate of Analysis | Jun 14, 2024 | P612723 |
G2409112 | Certificate of Analysis | Jun 14, 2024 | P612723 |
Starting at $150.90
1. Wager TT, Pettersen BA, Schmidt AW, Spracklin DK, Mente S, Butler TW, Howard H, Lettiere DJ, Rubitski DM, Wong DF et al.. (2011) Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764).. J Med Chem, 54 (21): (7602-20). [PMID:21928839] |
2. Stokes JR, Romero Jr FA, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB. (2012) The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.. J Allergy Clin Immunol, 129 (2): (409-12, 412.e1-2). [PMID:22196768] |